Middle-East And Africa Companion Diagnostics Market Size Worth $222.1Million by 2022 | CAGR: 21.11%
Middle-East And Africa Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer)
(EMAILWIRE.COM, March 27, 2018 ) Middle-East and Africa Companion Diagnostics Market was worth USD 73.2 million in 2016 and estimated to be growing at a CAGR of 21.11%, to reach USD 222.1 million by 2022.
Companion diagnostic has the potential to totally modify the drug development process and commercialization of the drug diagnoses will make drugs with a better therapeutic efficiency in a faster and cost-effective way. Companion diagnostics has been extremely advantageous to identify patients with precise biomarkers that have predictive responses.
Innovative technologies such as next-generation sequencing (NGS), growing acceptance of companion diagnostic kits/tests by the pharmaceutical industry and boost from controlling bodies are anticipated to enhance the market. NGS-based companion diagnostics is one of the major factors that will drive the market due to its ability of identifying multiple genes at a single time. Regulatory uncertainty and cost allied with developing drugs are expected to hamper the market growth of companion diagnostic market.
Get a comprehensive overview of the Market: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-companion-diagnostics-market-645/
The Middle-East and Africa clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.
Request for Sample Brochure: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-companion-diagnostics-market-645/request-sample
Based on geography the Middle-East and Africa market is analysed under various regions namely, Middle-East and Africa. Africa is expected to grow at highest CAGR in this region for the coming years.
Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.
scope of the report provides:
• The evaluation of the current market for your product or services and the future implications of the market
• Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
• Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
• Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
• The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
• The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
• Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
• Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
• Equip you with the information providing with the investment opportunities in the industry
• Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Companion diagnostic has the potential to totally modify the drug development process and commercialization of the drug diagnoses will make drugs with a better therapeutic efficiency in a faster and cost-effective way. Companion diagnostics has been extremely advantageous to identify patients with precise biomarkers that have predictive responses.
Innovative technologies such as next-generation sequencing (NGS), growing acceptance of companion diagnostic kits/tests by the pharmaceutical industry and boost from controlling bodies are anticipated to enhance the market. NGS-based companion diagnostics is one of the major factors that will drive the market due to its ability of identifying multiple genes at a single time. Regulatory uncertainty and cost allied with developing drugs are expected to hamper the market growth of companion diagnostic market.
Get a comprehensive overview of the Market: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-companion-diagnostics-market-645/
The Middle-East and Africa clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.
Request for Sample Brochure: https://www.marketdataforecast.com/market-reports/middle-east-and-africa-companion-diagnostics-market-645/request-sample
Based on geography the Middle-East and Africa market is analysed under various regions namely, Middle-East and Africa. Africa is expected to grow at highest CAGR in this region for the coming years.
Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.
scope of the report provides:
• The evaluation of the current market for your product or services and the future implications of the market
• Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
• Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
• Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
• The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
• The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
• Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
• Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
• Equip you with the information providing with the investment opportunities in the industry
• Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results